▶ 調査レポート

がんゲノムシーケンシングの世界市場:市場規模・現状・予測

• 英文タイトル:Global Cancer Genome Sequencing Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。がんゲノムシーケンシングの世界市場:市場規模・現状・予測 / Global Cancer Genome Sequencing Market Size, Status and Forecast 2019-2025 / QYR9ST04748資料のイメージです。• レポートコード:QYR9ST04748
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、がんゲノムシーケンシングの世界市場について調査・分析し、がんゲノムシーケンシングの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(二代目、三代目)、用途別(治療、研究)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界のがんゲノムシーケンシング市場動向
・主要企業別マーケットシェア
・がんゲノムシーケンシングの種類別市場規模2014-2019
(二代目、三代目)
・がんゲノムシーケンシングの用途別市場規模2014-2019
(治療、研究)
・がんゲノムシーケンシングの北米市場:主要企業・種類別/用途別市場規模
・がんゲノムシーケンシングのヨーロッパ市場:主要企業・種類別/用途別市場規模
・がんゲノムシーケンシングの中国市場:主要企業・種類別/用途別市場規模
・がんゲノムシーケンシングの日本国内市場:主要企業・種類別/用途別市場規模
・がんゲノムシーケンシングの東南アジア市場:主要企業・種類別/用途別市場規模
・がんゲノムシーケンシングのインド市場:主要企業・種類別/用途別市場規模
・がんゲノムシーケンシングの中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Agilent Technologies、GE Healthcare Life Sciences、Johnson & Johnson、LI-COR Biosciences、Abbott Laboratories、Beckman Coulter、Bayer Corporation、Hamilton Thorne Biosciences、Integrated DNA Technologies、Microchip Biotechnologies、Myriad Genetics、Commonwealth Biotechnologies、ZS Genetics、Pacific Biosciences)
・がんゲノムシーケンシングの市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells.It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumor micro environment (such as stromal / fibroblast cells), adjacent or distal normal tissue, or metastatic tumor sites. This technique generates information related to identification of nucleotide bases (DNA or RNA), mutation status, copy number and sequence variants, as well as structural variations including fusion genes and chromosomal translocations.
In 2018, the global Cancer Genome Sequencing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cancer Genome Sequencing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Genome Sequencing development in United States, Europe and China.

The key players covered in this study
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer Corporation
Hamilton Thorne Biosciences
Integrated DNA Technologies
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences

Market segment by Type, the product can be split into
Second generation
Third generation

Market segment by Application, split into
Treatment
Research

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cancer Genome Sequencing status, future forecast, growth opportunity, key market and key players.
To present the Cancer Genome Sequencing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Genome Sequencing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Genome Sequencing Market Size Growth Rate by Type (2014-2025)
1.4.2 Second generation
1.4.3 Third generation
1.5 Market by Application
1.5.1 Global Cancer Genome Sequencing Market Share by Application (2014-2025)
1.5.2 Treatment
1.5.3 Research
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cancer Genome Sequencing Market Size
2.2 Cancer Genome Sequencing Growth Trends by Regions
2.2.1 Cancer Genome Sequencing Market Size by Regions (2014-2025)
2.2.2 Cancer Genome Sequencing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cancer Genome Sequencing Market Size by Manufacturers
3.1.1 Global Cancer Genome Sequencing Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Genome Sequencing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Genome Sequencing Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Genome Sequencing Key Players Head office and Area Served
3.3 Key Players Cancer Genome Sequencing Product/Solution/Service
3.4 Date of Enter into Cancer Genome Sequencing Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cancer Genome Sequencing Market Size by Type (2014-2019)
4.2 Global Cancer Genome Sequencing Market Size by Application (2014-2019)

5 United States
5.1 United States Cancer Genome Sequencing Market Size (2014-2019)
5.2 Cancer Genome Sequencing Key Players in United States
5.3 United States Cancer Genome Sequencing Market Size by Type
5.4 United States Cancer Genome Sequencing Market Size by Application

6 Europe
6.1 Europe Cancer Genome Sequencing Market Size (2014-2019)
6.2 Cancer Genome Sequencing Key Players in Europe
6.3 Europe Cancer Genome Sequencing Market Size by Type
6.4 Europe Cancer Genome Sequencing Market Size by Application

7 China
7.1 China Cancer Genome Sequencing Market Size (2014-2019)
7.2 Cancer Genome Sequencing Key Players in China
7.3 China Cancer Genome Sequencing Market Size by Type
7.4 China Cancer Genome Sequencing Market Size by Application

8 Japan
8.1 Japan Cancer Genome Sequencing Market Size (2014-2019)
8.2 Cancer Genome Sequencing Key Players in Japan
8.3 Japan Cancer Genome Sequencing Market Size by Type
8.4 Japan Cancer Genome Sequencing Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cancer Genome Sequencing Market Size (2014-2019)
9.2 Cancer Genome Sequencing Key Players in Southeast Asia
9.3 Southeast Asia Cancer Genome Sequencing Market Size by Type
9.4 Southeast Asia Cancer Genome Sequencing Market Size by Application

10 India
10.1 India Cancer Genome Sequencing Market Size (2014-2019)
10.2 Cancer Genome Sequencing Key Players in India
10.3 India Cancer Genome Sequencing Market Size by Type
10.4 India Cancer Genome Sequencing Market Size by Application

11 Central & South America
11.1 Central & South America Cancer Genome Sequencing Market Size (2014-2019)
11.2 Cancer Genome Sequencing Key Players in Central & South America
11.3 Central & South America Cancer Genome Sequencing Market Size by Type
11.4 Central & South America Cancer Genome Sequencing Market Size by Application

12 International Players Profiles
12.1 Agilent Technologies
12.1.1 Agilent Technologies Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Genome Sequencing Introduction
12.1.4 Agilent Technologies Revenue in Cancer Genome Sequencing Business (2014-2019)
12.1.5 Agilent Technologies Recent Development
12.2 GE Healthcare Life Sciences
12.2.1 GE Healthcare Life Sciences Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Genome Sequencing Introduction
12.2.4 GE Healthcare Life Sciences Revenue in Cancer Genome Sequencing Business (2014-2019)
12.2.5 GE Healthcare Life Sciences Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Genome Sequencing Introduction
12.3.4 Johnson & Johnson Revenue in Cancer Genome Sequencing Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 LI-COR Biosciences
12.4.1 LI-COR Biosciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Genome Sequencing Introduction
12.4.4 LI-COR Biosciences Revenue in Cancer Genome Sequencing Business (2014-2019)
12.4.5 LI-COR Biosciences Recent Development
12.5 Abbott Laboratories
12.5.1 Abbott Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Genome Sequencing Introduction
12.5.4 Abbott Laboratories Revenue in Cancer Genome Sequencing Business (2014-2019)
12.5.5 Abbott Laboratories Recent Development
12.6 Beckman Coulter
12.6.1 Beckman Coulter Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Genome Sequencing Introduction
12.6.4 Beckman Coulter Revenue in Cancer Genome Sequencing Business (2014-2019)
12.6.5 Beckman Coulter Recent Development
12.7 Bayer Corporation
12.7.1 Bayer Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Genome Sequencing Introduction
12.7.4 Bayer Corporation Revenue in Cancer Genome Sequencing Business (2014-2019)
12.7.5 Bayer Corporation Recent Development
12.8 Hamilton Thorne Biosciences
12.8.1 Hamilton Thorne Biosciences Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Genome Sequencing Introduction
12.8.4 Hamilton Thorne Biosciences Revenue in Cancer Genome Sequencing Business (2014-2019)
12.8.5 Hamilton Thorne Biosciences Recent Development
12.9 Integrated DNA Technologies
12.9.1 Integrated DNA Technologies Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Genome Sequencing Introduction
12.9.4 Integrated DNA Technologies Revenue in Cancer Genome Sequencing Business (2014-2019)
12.9.5 Integrated DNA Technologies Recent Development
12.10 Microchip Biotechnologies
12.10.1 Microchip Biotechnologies Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Genome Sequencing Introduction
12.10.4 Microchip Biotechnologies Revenue in Cancer Genome Sequencing Business (2014-2019)
12.10.5 Microchip Biotechnologies Recent Development
12.11 Myriad Genetics
12.12 Commonwealth Biotechnologies
12.13 ZS Genetics
12.14 Pacific Biosciences

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Cancer Genome Sequencing Key Market Segments
Table Key Players Cancer Genome Sequencing Covered
Table Global Cancer Genome Sequencing Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cancer Genome Sequencing Market Size Market Share by Type 2014-2025
Figure Second generation Figures
Table Key Players of Second generation
Figure Third generation Figures
Table Key Players of Third generation
Table Global Cancer Genome Sequencing Market Size Growth by Application 2014-2025 (Million US$)
Figure Treatment Case Studies
Figure Research Case Studies
Figure Cancer Genome Sequencing Report Years Considered
Table Global Cancer Genome Sequencing Market Size 2014-2025 (Million US$)
Figure Global Cancer Genome Sequencing Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cancer Genome Sequencing Market Size by Regions 2014-2025 (Million US$)
Table Global Cancer Genome Sequencing Market Size by Regions 2014-2019 (Million US$)
Table Global Cancer Genome Sequencing Market Share by Regions 2014-2019
Figure Global Cancer Genome Sequencing Market Share by Regions 2014-2019
Figure Global Cancer Genome Sequencing Market Share by Regions 2019
Table Market Top Trends
Table Global Cancer Genome Sequencing Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cancer Genome Sequencing Market Share by Manufacturers (2014-2019)
Figure Global Cancer Genome Sequencing Market Share by Manufacturers in 2018
Table Global Cancer Genome Sequencing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Genome Sequencing Product/Solution/Service
Table Date of Enter into Cancer Genome Sequencing Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Genome Sequencing Market Size by Type (2014-2019) (Million US$)
Table Global Cancer Genome Sequencing Market Size Share by Type (2014-2019)
Figure Global Cancer Genome Sequencing Market Size Market Share by Type (2014-2019)
Table Global Cancer Genome Sequencing Market Size by Application (2014-2019) (Million US$)
Table Global Cancer Genome Sequencing Market Size Share by Application (2014-2019)
Figure Global Cancer Genome Sequencing Market Size Market Share by Application (2014-2019)
Figure Global Cancer Genome Sequencing Revenue Market Share by Application in 2018
Figure United States Cancer Genome Sequencing Market Size 2014-2019 (Million US$)
Table United States Key Players Cancer Genome Sequencing Revenue (2018-2019) (Million US$)
Table United States Key Players Cancer Genome Sequencing Market Share (2018-2019)
Table United States Cancer Genome Sequencing Market Size by Type (2014-2019) (Million US$)
Table United States Cancer Genome Sequencing Market Share by Type (2014-2019)
Table United States Cancer Genome Sequencing Market Size by Application (2014-2019) (Million US$)
Table United States Cancer Genome Sequencing Market Share by Application (2014-2019)
Figure Europe Cancer Genome Sequencing Market Size 2014-2019 (Million US$)
Table Europe Key Players Cancer Genome Sequencing Revenue (2018-2019) (Million US$)
Table Europe Key Players Cancer Genome Sequencing Market Share (2018-2019)
Table Europe Cancer Genome Sequencing Market Size by Type (2014-2019) (Million US$)
Table Europe Cancer Genome Sequencing Market Share by Type (2014-2019)
Table Europe Cancer Genome Sequencing Market Size by Application (2014-2019) (Million US$)
Table Europe Cancer Genome Sequencing Market Share by Application (2014-2019)
Figure China Cancer Genome Sequencing Market Size 2014-2019 (Million US$)
Table China Key Players Cancer Genome Sequencing Revenue (2018-2019) (Million US$)
Table China Key Players Cancer Genome Sequencing Market Share (2018-2019)
Table China Cancer Genome Sequencing Market Size by Type (2014-20189) (Million US$)
Table China Cancer Genome Sequencing Market Share by Type (2014-2019)
Table China Cancer Genome Sequencing Market Size by Application (2014-2019) (Million US$)
Table China Cancer Genome Sequencing Market Share by Application (2014-2019)
Figure Japan Cancer Genome Sequencing Market Size 2014-2019 (Million US$)
Table Japan Key Players Cancer Genome Sequencing Revenue (2018-2019) (Million US$)
Table Japan Key Players Cancer Genome Sequencing Market Share (2018-2019)
Table Japan Cancer Genome Sequencing Market Size by Type (2014-2019) (Million US$)
Table Japan Cancer Genome Sequencing Market Share by Type (2014-2019)
Table Japan Cancer Genome Sequencing Market Size by Application (2014-2019) (Million US$)
Table Japan Cancer Genome Sequencing Market Share by Application (2014-2019)
Figure Southeast Asia Cancer Genome Sequencing Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cancer Genome Sequencing Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cancer Genome Sequencing Market Share (2018-2019)
Table Southeast Asia Cancer Genome Sequencing Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cancer Genome Sequencing Market Share by Type (2014-2019)
Table Southeast Asia Cancer Genome Sequencing Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cancer Genome Sequencing Market Share by Application (2014-2019)
Figure India Cancer Genome Sequencing Market Size 2014-2019 (Million US$)
Table India Key Players Cancer Genome Sequencing Revenue (2018-2019) (Million US$)
Table India Key Players Cancer Genome Sequencing Market Share (2018-2019)
Table India Cancer Genome Sequencing Market Size by Type (2014-2019) (Million US$)
Table India Cancer Genome Sequencing Market Share by Type (2014-2019)
Table India Cancer Genome Sequencing Market Size by Application (2014-2019) (Million US$)
Table India Cancer Genome Sequencing Market Share by Application (2014-2019)
Figure Central & South America Cancer Genome Sequencing Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cancer Genome Sequencing Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cancer Genome Sequencing Market Share (2018-2019)
Table Central & South America Cancer Genome Sequencing Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cancer Genome Sequencing Market Share by Type (2014-2019)
Table Central & South America Cancer Genome Sequencing Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cancer Genome Sequencing Market Share by Application (2014-2019)
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Cancer Genome Sequencing Business (2014-2019) (Million US$)
Figure Agilent Technologies Revenue Growth Rate in Cancer Genome Sequencing Business (2014-2019)
Table Agilent Technologies Recent Development
Table GE Healthcare Life Sciences Company Details
Table GE Healthcare Life Sciences Revenue in Cancer Genome Sequencing Business (2014-2019)(Million US$)
Figure GE Healthcare Life Sciences Revenue Growth Rate in Cancer Genome Sequencing Business (2014-2019)
Table GE Healthcare Life Sciences Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Cancer Genome Sequencing Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Cancer Genome Sequencing Business (2014-2019)
Table Johnson & Johnson Recent Development
Table LI-COR Biosciences Company Details
Table LI-COR Biosciences Revenue in Cancer Genome Sequencing Business (2014-2019)(Million US$)
Figure LI-COR Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2014-2019)
Table LI-COR Biosciences Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Cancer Genome Sequencing Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Cancer Genome Sequencing Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Beckman Coulter Company Details
Table Beckman Coulter Revenue in Cancer Genome Sequencing Business (2014-2019)(Million US$)
Figure Beckman Coulter Revenue Growth Rate in Cancer Genome Sequencing Business (2014-2019)
Table Beckman Coulter Recent Development
Table Bayer Corporation Company Details
Table Bayer Corporation Revenue in Cancer Genome Sequencing Business (2014-2019)(Million US$)
Figure Bayer Corporation Revenue Growth Rate in Cancer Genome Sequencing Business (2014-2019)
Table Bayer Corporation Recent Development
Table Hamilton Thorne Biosciences Company Details
Table Hamilton Thorne Biosciences Revenue in Cancer Genome Sequencing Business (2014-2019)(Million US$)
Figure Hamilton Thorne Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2014-2019)
Table Hamilton Thorne Biosciences Recent Development
Table Integrated DNA Technologies Company Details
Table Integrated DNA Technologies Revenue in Cancer Genome Sequencing Business (2014-2019)(Million US$)
Figure Integrated DNA Technologies Revenue Growth Rate in Cancer Genome Sequencing Business (2014-2019)
Table Integrated DNA Technologies Recent Development
Table Microchip Biotechnologies Company Details
Table Microchip Biotechnologies Revenue in Cancer Genome Sequencing Business (2014-2019)(Million US$)
Figure Microchip Biotechnologies Revenue Growth Rate in Cancer Genome Sequencing Business (2014-2019)
Table Microchip Biotechnologies Recent Development
Table Myriad Genetics Company Details
Table Commonwealth Biotechnologies Company Details
Table ZS Genetics Company Details
Table Pacific Biosciences Company Details
Table Global Cancer Genome Sequencing Market Size by Regions (Million US$) 2019-2025
Figure Global Cancer Genome Sequencing Market Size Share by Regions (2019-2025)
Figure Global Cancer Genome Sequencing Market Size Share by Regions in 2025
Figure United States Cancer Genome Sequencing Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cancer Genome Sequencing Market Size Forecast (2019-2025)(Million USD)
Figure China Cancer Genome Sequencing Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cancer Genome Sequencing Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cancer Genome Sequencing Market Size Forecast (2019-2025)(Million USD)
Figure India Cancer Genome Sequencing Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cancer Genome Sequencing Market Size Forecast (2019-2025)(Million USD)
Table Global Cancer Genome Sequencing Market Size by Product (2019-2025) (Million US$)
Figure Global Cancer Genome Sequencing Market Size by Product (2019-2025)
Figure Global Cancer Genome Sequencing Market Size by Product in 2025
Table Global Cancer Genome Sequencing Market Size by Application (2019-2025) (Million US$)
Figure Global Cancer Genome Sequencing Market Size by Application (2019-2025)
Figure Global Cancer Genome Sequencing Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources